ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

August 20, 1982

In Brief: Reagan Names Hammer to Third Term As Cancer Panel chairman; RPMI Opens Survivor Clinic

July 31, 1987

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

In Brief: DeVita Receives Griffuel Prize; Commission On Ethics To Take Up Compensation Question

December 12, 1980

In Brief: Schwarzkopf In NCCS TV Spot; AACI elects Officers; Nobel Prize In Medicine awarded

October 18, 1996

HHS News: Skin Cancer Awareness Initiative Begun

May 29, 1998